Global Retinal Disorder Treatment Market by Type (Diabetic Retinopathy, Macular Degeneration), Dosage Form (Capsules & Tablets, Eye Drops, Eye Solutions), Distribution Channel - Forecast 2024-2030- Product Image

Sale

Global Retinal Disorder Treatment Market by Type (Diabetic Retinopathy, Macular Degeneration), Dosage Form (Capsules & Tablets, Eye Drops, Eye Solutions), Distribution Channel - Forecast 2024-2030

Report
199 Pages
March 2024
Region: Global
360iResearch™
ID: 5313726

UP TO €846EUR$875USD£725GBP OFF until Dec 31^st 2024

The Retinal Disorder Treatment Market size was estimated at USD 8.62 billion in 2023, USD 9.38 billion in 2024, and is expected to grow at a CAGR of 8.94% to reach USD 15.70 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Retinal Disorder Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Retinal Disorder Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Retinal Disorder Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Abeona Therapeutics Inc., Apellis Pharmaceuticals, Inc., Bausch & Lomb Incorporated, Bayer AG, F. Hoffmann-La Roche Ltd., Graybug Vision Inc., Kubota Pharmaceutical Holdings Co., Ltd., Novartis AG, ONL Therapeutics, Opthea, Oxford Biomedica PLC, Oxurion NV, Pfizer, Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co., Ltd., and Spark Therapeutics, Inc.

Market Segmentation & Coverage

This research report categorizes the Retinal Disorder Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Diabetic Retinopathy
- Macular Degeneration
  - Dry Macular Degeneration
  - Wet Macular Degeneration
Dosage Form
- Capsules & Tablets
- Eye Drops
- Eye Solutions
- Gels
- Ointments
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Retinal Disorder Treatment Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Retinal Disorder Treatment Market?
What are the technology trends and regulatory frameworks in the Retinal Disorder Treatment Market?
What is the market share of the leading vendors in the Retinal Disorder Treatment Market?
Which modes and strategic moves are suitable for entering the Retinal Disorder Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Retinal Disorder Treatment Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing funding by regulatory bodies for research on ocular disorders
5.1.1.2. Increasing prevalence of retinal disorders globally
5.1.1.3. Rising elderly population coupled with macular degeneration
5.1.2. Restraints
5.1.2.1. High cost involved in research and development activities
5.1.3. Opportunities
5.1.3.1. Technological innovations and advancements in treatments
5.1.3.2. Growing strategic collaborations and commercialization of novel products
5.1.4. Challenges
5.1.4.1. Probable complications in the eye
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Retinal Disorder Treatment Market, by Type

6.1. Introduction
6.2. Diabetic Retinopathy
6.3. Macular Degeneration
6.4.1. Dry Macular Degeneration
6.4.2. Wet Macular Degeneration

7. Retinal Disorder Treatment Market, by Dosage Form

7.1. Introduction
7.2. Capsules & Tablets
7.3. Eye Drops
7.4. Eye Solutions
7.5. Gels
7.6. Ointments

8. Retinal Disorder Treatment Market, by Distribution Channel

8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy

9. Americas Retinal Disorder Treatment Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Retinal Disorder Treatment Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Retinal Disorder Treatment Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. AbbVie Inc.
13.1.2. Abeona Therapeutics Inc.
13.1.3. Apellis Pharmaceuticals, Inc.
13.1.4. Bausch & Lomb Incorporated
13.1.5. Bayer AG
13.1.6. F. Hoffmann-La Roche Ltd.
13.1.7. Graybug Vision Inc.
13.1.8. Kubota Pharmaceutical Holdings Co., Ltd.
13.1.9. Novartis AG
13.1.10. ONL Therapeutics
13.1.11. Opthea
13.1.12. Oxford Biomedica PLC
13.1.13. Oxurion NV
13.1.14. Pfizer, Inc.
13.1.15. Regeneron Pharmaceuticals Inc.
13.1.16. Santen Pharmaceutical Co., Ltd.
13.1.17. Spark Therapeutics, Inc.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. RETINAL DISORDER TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. RETINAL DISORDER TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. RETINAL DISORDER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RETINAL DISORDER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. RETINAL DISORDER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RETINAL DISORDER TREATMENT MARKET DYNAMICS
FIGURE 7. RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
FIGURE 10. RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. RETINAL DISORDER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. RETINAL DISORDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. RETINAL DISORDER TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. RETINAL DISORDER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 9. RETINAL DISORDER TREATMENT MARKET SIZE, BY DRY MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. RETINAL DISORDER TREATMENT MARKET SIZE, BY WET MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 12. RETINAL DISORDER TREATMENT MARKET SIZE, BY CAPSULES & TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. RETINAL DISORDER TREATMENT MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. RETINAL DISORDER TREATMENT MARKET SIZE, BY EYE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. RETINAL DISORDER TREATMENT MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. RETINAL DISORDER TREATMENT MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 18. RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. RETINAL DISORDER TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. RETINAL DISORDER TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 36. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 37. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 40. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 41. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. CHINA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. CHINA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 58. CHINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 59. CHINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. INDIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. INDIA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 62. INDIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 63. INDIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. JAPAN RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. JAPAN RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 70. JAPAN RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 71. JAPAN RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. THAILAND RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. THAILAND RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 94. THAILAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 95. THAILAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 107. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 108. DENMARK RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. EGYPT RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. EGYPT RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 111. EGYPT RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 112. EGYPT RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 115. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 116. FINLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 120. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 124. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 131. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 132. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. NORWAY RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. NORWAY RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 143. NORWAY RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 144. NORWAY RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. POLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. POLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 147. POLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 148. POLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 151. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 152. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 168. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. TURKEY RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. TURKEY RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 179. TURKEY RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 180. TURKEY RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. RETINAL DISORDER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 190. RETINAL DISORDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 191. RETINAL DISORDER TREATMENT MARKET LICENSE & PRICING

Companies Mentioned

AbbVie Inc.
Abeona Therapeutics Inc.
Apellis Pharmaceuticals, Inc.
Bausch & Lomb Incorporated
Bayer AG
F. Hoffmann-La Roche Ltd.
Graybug Vision Inc.
Kubota Pharmaceutical Holdings Co., Ltd.
Novartis AG
ONL Therapeutics
Opthea
Oxford Biomedica PLC
Oxurion NV
Pfizer, Inc.
Regeneron Pharmaceuticals Inc.
Santen Pharmaceutical Co., Ltd.
Spark Therapeutics, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	199
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 9.38 Billion
Forecasted Market Value ( USD ) by 2030	$ 15.7 Billion
Compound Annual Growth Rate	8.9%
Regions Covered	Global
No. of Companies Mentioned	17

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3263EUR$3,374USD£2,796GBP €3625EUR$3,749USD£3,107GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,542GBP €4593EUR$4,749USD£3,936GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5004EUR$5,174USD£4,288GBP €5560EUR$5,749USD£4,765GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5874EUR$6,074USD£5,034GBP €6527EUR$6,749USD£5,594GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7615EUR$7,874USD£6,526GBP €8461EUR$8,749USD£7,251GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Retinal Disorder Treatment Global Market Report 2024

Retinal Disorder Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Type, By Dosage Form, By Distribution Channel, By Region and Competition

Global Retinal Disorder Treatment Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Macular Degeneration Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

Macular Degeneration Treatment Global Market Report 2024